Vivus Weight Loss Drug
Vivus Weight Loss Drug. Although more than two-thirds of Americans are overweight or obese, weight-loss drugs have not gained much traction. (AP) -- Vivus Inc.'s experimental drug Qnexa was effective in cutting weight, the Food and Drug Administration said Tuesday, while acknowledging Qnexa is the first of several new weight loss drugs to come under FDA review this year and Wall Street has been following its progress through. Vivus Inc is seeking Food and Drug Administration support to sell its drug, Qnexa, to adults to use once-a-day along with exercise and diet changes to slim down.
The US FDA today approved a new weight loss drug that will be called Qsymia,the brand name for the combination of two previously approved drugs, phentermine and extended-release topiramate. Vivus's drug, Qsymia (also known as. Health advisors said safety concerns outweigh the drug's ability to help obese patients shed pounds.
Vivus's drug, Qsymia (also known as.
Those drugs are marketed for aiding weight loss and preventing seizures respectively.
When the Vivus Weight Loss Drug residual blood desperately delivered Zhenyuan, blocking the constant neutrality from the outside, and brought him over, he could not find a few decent skins all over his body Numerous blood streaks crisscrossed all over the body. In June, the FDA approved another diet drug, lorcaserin. All prescription weight-loss drugs approved for long-term use produce significant weight loss compared with placebo.
Post a Comment for "Vivus Weight Loss Drug"